Skip to main navigation Skip to search Skip to main content

Neoadjuvant radiochemotherapy for locally advanced gastric cancer: a] I-II study

  • AD Roth
  • , AS Allal
  • , Marie-Anne Brundler
  • , R de Peyer
  • , B Mermillod
  • , I More
  • , P Huber

    Research output: Contribution to journalArticle

    43 Citations (Scopus)

    Abstract

    BACKGROUND: To study in a phase I-II trial the maximum tolerated dose, the toxicity, and the tolerance of adding radiotherapy to systemic chemotherapy administered preoperatively in patients with locoregionally advanced gastric adenocarcinoma. PATIENTS AND METHODS: Patients with adenocarcinoma of the stomach (T(3)(-)(4)N(any) or T(any)N+), performance status
    Original languageEnglish
    Pages (from-to)110-115
    Number of pages6
    JournalAnnals of Oncology
    Volume14
    Issue number1
    DOIs
    Publication statusPublished - 1 Jan 2003

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Fingerprint

    Dive into the research topics of 'Neoadjuvant radiochemotherapy for locally advanced gastric cancer: a] I-II study'. Together they form a unique fingerprint.

    Cite this